Hello riskreturn168: I am a new AMBS investor and new to posting on this board. I have seen recent posts from you indicating that you'll quit posting here if the AMBS pps is below $0.20 by October 1, 2014. I, for one, hope very much that you are kidding. While I think this is a fairly safe bet, I'd hate to see you leave the board if the pps fails to hit this mark. I have always found your posts to helpful and informational. Some of your recent posts to folks with alternative views has been disappointing because I believe you are far to knowledgeable here to risk ruining your credibility by worrying about others with different views and approaches. I say that with the utmost respect and my hope that you'll return to your insightful and informative posts about your beliefs and opinions regarding the future of this company.
I am interested in your best guess on what we might expect to hear about Lympro revenue projections (how much and when) during next weeks conference call. I realize that only qualitative figures will be discussed but I personally believe these estimates will give us all a solid view of "how big the bread box" is with Lympro. September could be a huge and significant month for AMBS. I appreciate your thoughts. Good luck to you sir.
Hi Professor, have my attacks on all you other aliases made you go invent new ones? That's a shame!
Revenue Guidance? I have no basis for actually numbers. In general my description of what I expect is very MODEST revenue for the first half of 2015 while LymPro is ramping up with Big Pharma doing clinical trials. Very MODERATE revenue during the second half of 2015. And then OUTRAGEOUS revenue for the first half of 2016, and upwards from there. This represents the kind of "revenue curve" I am expecting, from modest to outrageous in 18 months!. If I had to guess with actual numbers? I would be surprised if the 2015 revenue were any less than 20 million or any more than 70 million. So I'd say the 20 million to 70 million range for 2015 represents my expectations. That is revenue. I don't know what their "earnings" or profits would be on this range of revenue. Certainly less. 2016 the revenues should top 100 to 150 million. 2017 should top 250 to 300 million, I am guessing.
Thank you Risk. I am honestly not mkf or any of the other aliases you think may all be him. Just a new investor here and simply wanted your feedback on what you felt the Lympro numbers might be next week. I appeciate your response.